	Early, delayed, or combined contrast-enhanced mammography for detecting residual disease after neoadjuvant chemotherapy in breast cancer. Eur Radiol Bellini C, Bicchierai G, Maiello C, Amato F, de Benedetto D, di Naro F, Vidali S, Tonelli P, Vanzi E, Boeri C, Visani L, Vezzosi V, Orzalesi L, Susini T, Miele V, Nori J. PMID: 42141291 [PubMed - as supplied by publisher]
	Quantifying Breast Asymmetry Before and After Equal-Volume Subfascial Augmentation: the Volume-Shape Paradox. Aesthetic Plast Surg Brown T. PMID: 42141209 [PubMed - as supplied by publisher]
	Study on the synergistic efficacy and mechanism of CD24 silencing combined with trastuzumab in HER2-positive breast cancer. J Mol Histol Lu Y, Zhou X, Gao Y, Zhu Z, Deng B, Lv W, Fu Z, Ding H, Zhong L. PMID: 42141178 [PubMed - indexed for MEDLINE]
	Feasibility study of the Four-Session Cognitive-Behavioral Therapy-based Psychological Intervention Program for women with HER2-positive metastatic breast cancer. Support Care Cancer Szekeres T, Balázs MÁ, Madarász B, Póti Z, Urbán R, Dank M, Vizin G. PMID: 42141145 [PubMed - indexed for MEDLINE]
	Expert recommendations for PIK3CA testing in HR+/HER2- locally advanced and metastatic breast cancer. NPJ Breast Cancer Marchiò C, Rojo F, Copson ER, Schmitt F, Bellosillo B, Fremd C. PMID: 42140989 [PubMed - as supplied by publisher]
	Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial. Nat Commun Garrido-Castro AC, Graham N, Li KX, Bi L, Crowdis J, Bi K, Park J, Pastorello R, Li Y, Gupta H, Kuntz T, Petry R, Pasquina LW, Patel A, Lange P, DiLullo M, Attaya V, Frey AM, Childress MA, Wesolowski R, Sinclair N, Sinclair S, Lo S, Tung N, Faggen M, Kaufman PA, Block CC, Walsh J, Toke M, Chen W, Wucherpfennig KW, Tian Y, Williams AJ, Mukhopadhyay S, Dasgupta T, Schnitt S, Cherniack AD, Barroso R, Ligibel J, Lin NU, Mittendorf EA, Tayob N, Van Allen E, Tolaney SM. PMID: 42140950 [PubMed - as supplied by publisher]
	Sequencing PARP inhibitors in breast cancer: lessons learned and emerging insights. NPJ Breast Cancer Aloss K, Frederick MI, Hassan S. PMID: 42140928 [PubMed - as supplied by publisher]
	Bidirectional association between breast cancer and cardiovascular disease: Longitudinal analysis of UK Biobank data. Atherosclerosis Liu Z, Du F, Zhao C, Xu C, Fu Z, Fan Y, Zhang B, Huang X, Lu Z, Jiang F, Huang Y, Guo X, Ma J. PMID: 42140725 [PubMed - indexed for MEDLINE]
	The Role of Health Literacy in Breast Cancer Treatment and Outcomes. J Natl Compr Canc Netw Bradley EM, Woodhouse P, Moses KA, Salwei ME, Sexton KW, Kripalani S, McCaffery RL, Idrees K. PMID: 42140267 [PubMed - indexed for MEDLINE]
	Navigating the future: An updated review and prospects for breast cancer vaccines. Int Immunopharmacol Roslei ASM, Huri HZ, Fisol FA, Nawaz A, Pratama DAOA, Sofian ZM, Jalil MFA, Nordin AH, Haron DEM, Norpi ASM, Azemi AK, Nordin ML. PMID: 42140162 [PubMed - as supplied by publisher]
	Understanding the unheard voices: A study on the experiences and perceptions of women using external breast prosthesis in Gujarat, India. Prosthet Orthot Int Suthar P, Namdeo N, Parmar K, Ganguly P, Joshi NK. PMID: 42139683 [PubMed - as supplied by publisher]
	Prognostic factors for breast cancer progression. Wiad Lek Chuprovska Y, Bodiaka V, Ivashchuk O, Morar I. PMID: 42139613 [PubMed - indexed for MEDLINE]
	Real world experience with cyclin dependent kinase inhibitors in metastatic breast cancer in India. PLoS One Mukherjee A, Goyal P, Tripathi R, Goyal S, Batra U, Talwar V, Goel V, Jain A, Saha S, Bothra S, Agrawal C, Chugh S, Doval DC. PMID: 42139194 [PubMed - indexed for MEDLINE]
	Breast, Cervical, and Colorectal Cancer Screening Rates in Women Aged 45 to 64 Years. JAMA Netw Open Spencer JC, Montealegre JR, Calderón-Mora J, Pignone MP. PMID: 42138919 [PubMed - indexed for MEDLINE]
	From tumor microenvironment orchestrators to actionable targets: a systematic review of TAM-targeted therapies in triple-negative breast cancer. Int J Clin Oncol Pei Y, Zhang J, Li C, Wang Y, Yu Q, Chen W. PMID: 42138756 [PubMed - as supplied by publisher]
	Contribution of FXR1 genetic polymorphisms to breast cancer susceptibility in Chinese females. Mol Genet Genomics Zhang C, Zhang G, Fida S, Zhang Y, Wang S, Zhang Z, Song C. PMID: 42138731 [PubMed - indexed for MEDLINE]
	Real-World adherence and quality of life Among HER2-positive breast cancer patients receiving subcutaneous trastuzumab in Ghana: A pilot study. J Oncol Pharm Pract Mensah KB, Boamah Mensah AB, Koampah DK, Ansah PB, Appiah-Num Safo AA, Amo R, Boatey L, Bangalee V. PMID: 42138423 [PubMed - as supplied by publisher]
	Outcomes With Immunotherapy in Hormone Receptor-Positive Breast Cancer: A Systematic Review and Meta-Analysis. Am J Clin Oncol Shahzad M, Amin MK, Kasaeian A, Tariq SM, Oskouie IM, Akram U, Aziz N, Warraich SZ, Khalid MF, Anwar I, Mushtaq MU, Jaglal M. PMID: 42138278 [PubMed - as supplied by publisher]
	RNAi-Loaded Exosomes for the Management of Breast Cancer: Emerging Paradigms in Precision Therapy. Adv Biol (Weinh) Kaur J, Famta P, Srivastava S, Thakur G, Awasthi A, Singh SK. PMID: 42138249 [PubMed - indexed for MEDLINE]
	Effect of a herbal galactagogic formula combined with auricular acupressure on breast milk production and hormonal profiles in women with postpartum hypogalactia: A randomized controlled study. Afr J Reprod Health Li K, Cai D, Gao Z, Liang X, Zhang D, Niu Y. PMID: 42138144 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 217682

Page 1 of 10885



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy